US Broker Ratings

RadNet, Inc. (RDNT) Stock Analysis: Why Analysts Predict a 24% Upside

RadNet, Inc. (NASDAQ: RDNT), a significant player in the healthcare sector, specifically in diagnostics and research, has captured the attention of individual investors and analysts alike. With a current market..

ADMA Biologics Inc (ADMA) Stock Analysis: A Promising 76% Potential Upside for Investors

ADMA Biologics Inc (NASDAQ: ADMA) is capturing the attention of investors with a robust potential upside of 76.27%, according to analyst ratings. Operating in the healthcare sector, specifically within the..

Soleno Therapeutics, Inc. (SLNO) Investor Outlook: Biotech Stock with a 27% Upside Potential

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is making headlines in the healthcare sector, specifically within the biotechnology industry, as it charts a promising path with its clinical-stage biopharmaceutical pursuits. Headquartered in..

Bio-Techne Corp (TECH) Investor Outlook: Analyzing the 29.33% Potential Upside

Bio-Techne Corp (NASDAQ: TECH), a prominent player in the biotechnology industry, is drawing attention from investors with its promising 29.33% potential upside. With a market capitalization of $8.16 billion, this..

Vaxcyte, Inc. (PCVX) Investor Outlook: Exploring a Potential 247% Upside with Groundbreaking Vaccine Innovations

Vaxcyte, Inc. (NASDAQ: PCVX) is navigating the biotechnology landscape with a promising portfolio of vaccines designed to combat bacterial infectious diseases. With a market capitalization of $4.67 billion, this clinical-stage..

Verona Pharma (VRNA) Stock Analysis: Strong Buy Ratings and 13.53% Potential Upside

Verona Pharma plc (NASDAQ: VRNA) is making waves in the biotechnology sector, capturing investor attention with its robust portfolio and promising market performance. Headquartered in London and operating in the..

Insmed Incorporated (INSM) Stock Analysis: A Biotech Innovator with 7.32% Potential Upside

Insmed Incorporated (NASDAQ: INSM) stands out in the biotechnology sector with its focus on developing and commercializing therapies for serious and rare diseases. With a market capitalization of $19.48 billion,..

Inspire Medical Systems, Inc. (INSP): Growth Potential and Analyst Ratings Signal a Bright Future

Inspire Medical Systems, Inc. (NASDAQ: INSP) is making waves in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $3.74 billion, Inspire Medical is at..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Promising 66.57% Potential Upside with Solid Analyst Support

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a key player in the biotechnology sector, is capturing investor attention with its robust portfolio and promising stock potential. Headquartered in Dublin, Ireland, the company..

Stevanato Group S.p.A. (STVN) Stock Analysis: A 14.91% Upside Potential Boosts Investor Confidence

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, is making waves in the medical instruments and supplies industry. With a market capitalization of $6.8 billion, this..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 19.76% Potential Upside

Agilent Technologies, Inc. (NYSE: A), a key player in the healthcare sector specializing in diagnostics and research, is making waves with its diverse portfolio of solutions tailored to the life..

DaVita Inc. (DVA) Stock Analysis: Evaluating Growth Potential Amidst Strong ROE and Revenue Growth

DaVita Inc. (NYSE: DVA) stands as a significant player in the healthcare sector, focusing on medical care facilities, specifically kidney dialysis services. With a market cap of $10.67 billion, DaVita’s..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Exploring a Potential 18.69% Upside in the Biotech Sector

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is making waves in the biotechnology sector, boasting a market capitalization of $6.96 billion. As a key player in the healthcare industry, this San Diego-based..

Viatris Inc. (VTRS) Stock Analysis: A Deep Dive into Its 28% Potential Upside for Investors

Viatris Inc. (NASDAQ: VTRS) finds itself at a critical juncture, poised with a potential upside of 28.24% according to analyst ratings, making it an intriguing prospect for investors. As a..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Potential Upside of Nearly 95% as Biotech Innovates Muscle Treatments

Cytokinetics, Incorporated (NASDAQ: CYTK) is making waves in the biotechnology sector with a promising portfolio of muscle activators and inhibitors aimed at treating debilitating diseases. The company, headquartered in South..

Ascendis Pharma A/S (ASND) Stock Analysis: 35% Potential Upside Attracts Buy Ratings

Ascendis Pharma A/S (NASDAQ: ASND) is capturing the attention of the investment community, offering a tantalizing potential upside of 35.11% according to analysts’ projections. Based in Hellerup, Denmark, Ascendis is..

Biogen Inc. (BIIB) Stock Analysis: Unveiling a 37.77% Potential Upside Amidst a Robust Neurological Portfolio

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector, remains a compelling focus for investors seeking exposure to the drug manufacturing industry. With a market capitalization of $18.31 billion,..

GSK plc (GSK) Stock Analysis: Healthcare Giant with 14.90% Upside Potential

GSK plc (GSK), a stalwart in the healthcare sector, commands significant investor attention due to its robust portfolio and promising growth trajectory. Traded on the London Stock Exchange, GSK is..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: High ROE and Strategic Growth in the Healthcare Diagnostics Sector

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the healthcare diagnostics and research industry, continues to capture investor attention with its substantial market capitalization of $41.39 billion. Headquartered in..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Evaluating a 15% Upside Potential

GE HealthCare Technologies Inc. (NYSE: GEHC), a prominent player in the healthcare sector, stands out as an intriguing investment opportunity for discerning investors. With a market capitalization of $34.78 billion,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds